Overview
Black hairy tongue (BHT) is a benign, often asymptomatic condition characterized by hypertrophy of the filiform papillae on the dorsal surface of the tongue, leading to a distinctive hairy appearance and discoloration ranging from yellowish-white to brown or black [PMID:2190456]. This condition primarily affects the filiform papillae, which become elongated and retain keratin, resulting in the characteristic appearance. BHT is relatively common, with reported prevalence rates varying widely from 0.6% to 11.3% across different populations [PMID:37904483]. Despite its benign nature, BHT can cause significant cosmetic distress and, in some cases, may be associated with mild symptoms such as halitosis, dysgeusia, and gagging [PMID:25152586]. The condition can affect individuals of all ages, from infants to elderly patients, highlighting its broad demographic reach [PMID:18476933]. Understanding the predisposing factors and triggers is crucial for both diagnosis and management.
Pathophysiology
The pathophysiology of BHT revolves around the hypertrophy and impaired desquamation of the filiform papillae. Keratin accumulation due to defective desquamation leads to the elongation and retention of keratin on these papillae, resulting in the characteristic discoloration [PMID:25538341]. This process is exacerbated by various predisposing factors, including smoking, excessive consumption of coffee or black tea, poor oral hygiene, and certain medications [PMID:25152586]. Antibiotics, particularly those that induce xerostomia, and drugs like olanzapine and fluoxetine, which can cause dry mouth, have been implicated in the development of BHT [PMID:20500047]. Histologically, BHT is characterized by hyperkeratosis and retention of secondary papillary cells expressing hair-type keratins, as evidenced by immunohistochemical studies [PMID:10052403]. These cellular changes underscore the importance of keratin metabolism in the pathogenesis of the condition.
Epidemiology
The prevalence of BHT varies significantly across different populations, ranging from 0.6% to 11.3%, with some studies reporting even higher rates up to 53.8% in specific subgroups [PMID:25152586]. This variability suggests that environmental and individual factors play a substantial role in its occurrence. BHT is not confined to adults; cases have been reported in pediatric patients, including a 2-month-old infant, indicating that age is not a limiting factor [PMID:18476933]. Certain medications, such as antibiotics (e.g., piperacillin-tazobactam, imipenem/cilastatin) and antipsychotics (e.g., olanzapine), have been linked to BHT development, emphasizing the importance of medication history in clinical assessment [PMID:33044871, PMID:31621928]. Additionally, lifestyle factors such as smoking and poor oral hygiene significantly increase the risk, underscoring the need for comprehensive patient history taking.
Clinical Presentation
Clinically, BHT is typically identified by the presence of elongated, hyperkeratotic filiform papillae on the dorsal surface of the tongue, often with a discoloration ranging from yellowish-white to brown or black [PMID:15679200]. While many patients remain asymptomatic, others may experience symptoms such as halitosis, dysgeusia, nausea, and a sensation of gagging [PMID:25152586]. These symptoms can significantly impact quality of life, particularly due to aesthetic concerns. The onset of BHT can be rapid, sometimes within days of initiating certain medications, as seen in cases involving linezolid and imipenem/cilastatin [PMID:25538341, PMID:31621928]. In pediatric cases, symptoms may include feeding difficulties secondary to discomfort, highlighting the condition's potential impact across all age groups [PMID:28967681].
Diagnosis
Diagnosis of BHT is primarily clinical, based on the characteristic appearance of the tongue. However, to rule out other conditions that may present similarly, clinicians should consider a thorough clinical evaluation, including a detailed history and physical examination [PMID:15679200]. Histopathological examination can provide definitive confirmation, showing hyperkeratosis and retention of secondary papillary cells expressing hair-type keratins [PMID:10052403]. In some cases, additional tests such as KOH mounts may be necessary to exclude fungal infections, which can mimic BHT [PMID:27298505]. The Naranjo adverse drug reaction probability scale can be useful in assessing causality when medication use is suspected [PMID:33044871]. Despite these diagnostic tools, the condition remains primarily identified through visual inspection and patient history.
Differential Diagnosis
Several conditions can mimic BHT, necessitating careful differential diagnosis. These include pseudo-BHT, acanthosis nigricans, oral hairy leukoplakia, pigmented fungiform papillae, and congenital melanocytic nevi [PMID:25152586]. Fungal infections, particularly oral candidiasis, should also be considered and ruled out through appropriate diagnostic tests like KOH smears [PMID:27298505]. Medication side effects, especially from antibiotics and drugs causing xerostomia, are critical to identify and exclude as potential causes [PMID:20500047]. Comprehensive patient history, including dietary habits, smoking status, and medication use, is essential in distinguishing BHT from these alternatives.
Management
The management of BHT focuses on addressing predisposing factors and improving oral hygiene. Discontinuation of the offending medication, if identified, is often the first step towards resolution [PMID:31621928]. Oral hygiene practices, such as gentle tongue cleaning with a soft-bristle toothbrush and regular mouth rinses, can significantly alleviate symptoms and promote recovery [PMID:33044871]. In cases where symptoms persist, physical removal of the elongated papillae through scraping or debridement may be necessary [PMID:20500047]. Topical treatments like tretinoin have shown promise as alternative therapies for resistant cases, expanding beyond conventional methods such as urea brushing and topical corticosteroids [PMID:1451290]. Traditional Chinese Medicine (TCM) approaches, including herbal treatments, have also demonstrated efficacy in managing BHT, particularly in cases with associated gastrointestinal symptoms [PMID:37904483].
Complications
While BHT is generally benign, it can lead to several complications that affect patient comfort and quality of life. Common complications include halitosis, dysgeusia, gagging, and nausea, which can be distressing despite the condition's benign nature [PMID:25152586]. In some instances, patients may experience burning mouth syndrome, further complicating their symptoms. Prompt management and addressing underlying causes can mitigate these complications, ensuring a quicker resolution and improved patient outcomes.
Special Populations
Special attention should be given to certain populations, particularly the elderly and pediatric patients, who may be more susceptible to BHT due to complex medication regimens or unique physiological factors. Elderly patients often take multiple medications, increasing the risk of drug-induced BHT, as exemplified by cases involving antipsychotics like olanzapine [PMID:27298505]. Pediatric cases, such as those associated with ranitidine use, highlight the need for healthcare providers to be vigilant about medication side effects in younger patients [PMID:28967681]. Tailored management strategies, considering age-specific predispositions and treatment responses, are crucial for effective care in these groups.
Key Recommendations
References
1 Kuo PY, Chen PH, Wu SH. Black hairy tongue treated with traditional Chinese medicine: A case report. Medicine 2023. link 2 Ren J, Zheng Y, Du H, Wang S, Liu L, Duan W et al.. Antibiotic-induced black hairy tongue: two case reports and a review of the literature. The Journal of international medical research 2020. link 3 Jhaj R, Gour PR, Asati DP. Black hairy tongue with a fixed dose combination of olanzapine and fluoxetine. Indian journal of pharmacology 2016. link 4 Balaji G, Maharani B, Ravichandran V, Parthasarathi T. Linezolid induced black hairy tongue. Indian journal of pharmacology 2014. link 5 Gurvits GE, Tan A. Black hairy tongue syndrome. World journal of gastroenterology 2014. link 6 Zhao S, Fan L, Feng J, Ma P. Reversible black tongue: A little known side effect of imipenem/cilastatin and evidence for novel mode of action. Journal of clinical pharmacy and therapeutics 2020. link 7 Akcaboy M, Sahin S, Zorlu P, Şenel S. Ranitidine-induced black tongue: A case report. Pediatric dermatology 2017. link 8 Thompson DF, Kessler TL. Drug-induced black hairy tongue. Pharmacotherapy 2010. link 9 Poulopoulos AK, Antoniades DZ, Epivatianos A, Grivea IN, Syrogiannopoulos GA. Black hairy tongue in a 2-month-old infant. Journal of paediatrics and child health 2008. link 10 Yuca K, Calka O, Kiroglu AF, Akdeniz N, Cankaya H. Hairy tongue: a case report. Acta oto-rhino-laryngologica Belgica 2004. link 11 Manabe M, Lim HW, Winzer M, Loomis CA. Architectural organization of filiform papillae in normal and black hairy tongue epithelium: dissection of differentiation pathways in a complex human epithelium according to their patterns of keratin expression. Archives of dermatology 1999. link 12 Langtry JA, Carr MM, Steele MC, Ive FA. Topical tretinoin: a new treatment for black hairy tongue (lingua villosa nigra). Clinical and experimental dermatology 1992. link 13 Sarti GM, Haddy RI, Schaffer D, Kihm J. Black hairy tongue. American family physician 1990. link